In this sense, a study in T2D patients with no dementia, that included race as a covariable, revealed no effects of insulin on traditional measures of AD-neuropathology, although lower Aβ42 levels were detected when compared with biguanide or SU users [359]. The gene discussed is INS; the disease is type 2 diabetes mellitus.